AFT Pharma strikes licensing deal with Swiss company to sell Maxigesic in 69 countries

AFT Pharma strikes licensing deal with Swiss company to sell Maxigesic in 69 countries
Fiona Rotherham
By Fiona Rotherham Feb. 29 (BusinessDesk) -  AFT Pharmaceuticals has reached agreement with privately-owned Swiss headquartered multinational pharmaceutical company Acino Pharma AG to out-license the Auckland drug-maker’s main product, the patented combination painkiller Maxigesic to a further 69 countries. The shares rose.  The agreement is to sell all oral dose forms of Maxigesic and Maxigesic 1V in four geographic regions – Saudi Arabia and Yemen, Central America and the Caribbean, Africa, and North Africa and Levant. AFT markets more...